NASDAQ:VANI

Vivani Medical Stock News

etoro logo Buy VANI
*Your capital is at risk
$1.28
-0.0200 (-1.54%)
At Close: Jun 03, 2026
Looking for biotech penny stocks on Reddit? Check these 3 out for your watchlist The post 3 Biotech Penny Stocks That Are Popular on Reddit Right Now appeared first on Penny Stocks to Buy, Picks, News
LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to c

EYES Stock: Over 30% Increase Intraday Explanation

01:08pm, Wednesday, 12'th May 2021
The stock price of Second Sight Medical Products Inc (NASDAQ: EYES) increased by over 30% during intraday trading. This is why it happened.
Second Sight Medical Products, Inc. (NASDAQ: EYES), Lucira Health, Inc. (NASDAQ: LHDX) and Ra Medical Systems, Inc. (NYSE: RMED) were among the biggest health care gainers Wednesday. Second Sight Rall
Second Sight Medical Products Inc. (NASDAQ: EYES) shares gapped up Wednesday morning following the two-year results from the company's Orion Study in visual prosthetics.  Four out of five patients a

Are These Penny Stocks The Biggest Morning Movers?

09:31am, Wednesday, 12'th May 2021
These penny stocks moved in early morning trading; will you add them to your watchlist? The post Are These Penny Stocks The Biggest Morning Movers?
LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer and marketer of implantable visual prosthetics that are
The stock price of Second Sight Medical Products Inc (NASDAQ: EYES) fell by over 6% pre-market. This is why it happened.
Investors are clamoring to find the next GameStop. Of the most shorted stocks right now, these are the candidates most primed for a squeeze.
The stock price of Second Sight Medical Products Inc (NASDAQ: EYES) increased by 27.43%. This is why it happened.
LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer and marketer of implantable visual prosthetics that are
Termination of the business combination with Second Sight Medical Products, Inc.
LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) (the "Company" or “Second Sight”), a leading developer and marketer of implantable visual prosthetics that are inte
Second Sight Will Probably Take a Second Look at Giving Up Control. EYES stock will probably rise if the company backs off of the sale of 60% to Pixium Vision.
Add in the pending capital raise, and dilution concerns are on the table as well. Speculative mania over low-priced stocks may help it hold onto most of its gains.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE